Stock Movers

iHeartPodcasts
undefined
7 snips
Dec 11, 2025 • 6min

Eli Lilly Gains on Experimental Shot, Gemini Space Station Rises, Oracle Sinks on 3Q Forecast

Eli Lilly's latest obesity drug shows remarkable potential, helping patients shed nearly 25% of their weight, along with other health benefits. Meanwhile, Gemini Space Station celebrates a 20% stock surge after gaining CFTC approval for a derivatives exchange, opening doors to prediction markets. On the downside, Oracle faces a hefty 13% drop as its cloud sales forecast disappoints, raising concerns about its revenue conversion amidst supply challenges.
undefined
Dec 11, 2025 • 4min

Oracle Falls on Disappointing Cloud Sales; Gemini Rallies; Eli Lilly Jumps

Oracle's latest cloud sales disappointed investors despite significant growth in its infrastructure business, as rising costs from AI data centers weigh on revenues. Meanwhile, Gemini Space Station saw its shares rally after gaining approval for a derivatives exchange, expanding its footprint in prediction markets. In other news, Eli Lilly's groundbreaking obesity drug showed impressive results in a late-stage study, sparking discussions on health and fitness.
undefined
Dec 11, 2025 • 3min

Gemini Space Station Rises, Oracle Slumps, Eli Lilly Rises on Experimental Shot Cutting Weight

Gemini Space Station's shares soar after securing a CFTC license for U.S. prediction markets, hinting at exciting growth ahead. In contrast, Oracle struggles as its cloud sales forecast disappoints, raising red flags about revenue conversion. Meanwhile, Eli Lilly's new obesity drug impresses, leading to nearly a 25% weight loss in patients, positioning it as a potential frontrunner in weight-loss treatments. Stay tuned for more insights in the market!
undefined
Dec 11, 2025 • 4min

Oracle Falls on Disappointing Cloud Sales; Eli Lilly Jumps; Gemini Rallies

Oracle's shares dipped as AI spending rises but cloud revenues fell short of expectations. Eli Lilly's new obesity drug showed promise, with patients losing over 23% of their weight in trials, boosting the company's stock. Meanwhile, Gemini's application for a derivatives exchange was approved, leading to a rise in their shares. Concerns also arose over regulatory issues affecting PDD, raising investor fears. The tech sector felt the impact of Oracle's disappointing results, affecting other major players.
undefined
Dec 11, 2025 • 4min

Schneider Electric Up, Entain Dips, Wizz Air Drops

Schneider Electric is making waves with a massive €3.5 billion share buyback plan, fueled by ambitions in AI and electrification. Meanwhile, Entain's Chief Financial Officer Rob Wood is set to step down in 2026, raising eyebrows around the company's future strategy amid regulatory pressures. Wizz Air faces challenges with a significant downgrade from analysts, citing rising costs and fierce competition from Ryanair. The outlook remains mixed as they navigate these turbulent times.
undefined
Dec 11, 2025 • 5min

Schneider Electric Gains, Delivery Hero Dips, Exosens Up

Schneider Electric plans a massive €3.5 billion share buyback to enhance profitability through AI and electrification. Meanwhile, Delivery Hero faces pressure with a rare sell rating from analysts due to mounting competition in the MENA region. In an intriguing turn, Exosens has secured a significant €500 million night-vision contract, boosting their stock and signaling strong potential in defense spending despite earlier selloffs.
undefined
7 snips
Dec 10, 2025 • 6min

Oracle Falls After Earnings, GE Vernova Soars, Uber Declines on Analyst Concerns

In this discussion, Natalia Kunijevich, a Bloomberg News equities reporter, dives into the latest market shifts. She reveals Oracle's disappointing cloud revenue tied to heavy AI spending, raising investor concerns. Meanwhile, GE Vernova celebrates a record 15.6% increase in stock value, fueled by rising dividends and strong demand in the AI sector. Lastly, Natalia highlights worries for Uber as analysts predict that Tesla and Waymo's autonomous vehicle advancements could threaten rideshare profitability by 2026.
undefined
Dec 10, 2025 • 10min

Closing Bell: GE Vernova's Biggest One-Day Gain, Warner Bros Higher, Oracle Falls on Earnings

GE Vernova achieved its largest one-day gain by soaring 15.6% after a dividend boost and promising earnings outlook thanks to rising demand for electricity driven by AI. Warner Bros Discovery's stock climbed 4.49% amid takeover talk, stirred by President Trump's remarks about CNN. However, Oracle's disappointing earnings led to a 6% drop in after-hours trading, raising concerns about its cloud revenue and AI strategy. Meanwhile, Cisco hit a 25-year high, highlighting the ongoing AI era's impact on stocks.
undefined
Dec 10, 2025 • 3min

Cracker Barrel Drops, GameStop Slides, PepsiCo Rises on Ratings Upgrade

Cracker Barrel is facing a significant sales decline, struggling after a logo change controversy. Meanwhile, GameStop reports a nearly 5% drop in net sales but highlights a surprising surge in collectibles, now a major revenue source. In a brighter turn, PepsiCo enjoys a ratings upgrade due to promising innovations and marketing strategies. The mix of traditional and emerging revenue streams paints an intriguing picture for these brands in a shifting market.
undefined
Dec 10, 2025 • 4min

GE Vernova Soars, Oracle Drops, Cracker Barrel Drops on Sales Forecast

GE Vernova is making waves with a 90% share increase after doubling dividends and boosting buybacks, driven by surging demand from data centers and AI. Meanwhile, Oracle faces turbulence as shares plummet ahead of a shaky earnings report and concerns about cash flow. In a surprising turn, Cracker Barrel's sales forecast dims following a backlash from a controversial logo change, reflecting ongoing challenges for the beloved chain. Tune in for insights on these market movers!

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app